Nifty
Sensex
:
:
17274.30
58065.47
386.95 (2.29%)
1276.66 (2.25%)

Pharmaceuticals & Drugs - Global

Rating :
56/99

BSE: 532331 | NSE: AJANTPHARM

1283.45
04-Oct-2022
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  • 1300.00
  • 1308.50
  • 1279.00
  • 1286.90
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  51133
  •  658.07
  •  1577.20
  •  1061.77

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 16,499.32
  • 23.19
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 16,289.44
  • 0.49%
  • 4.80

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 70.48%
  • 0.24%
  • 7.46%
  • FII
  • DII
  • Others
  • 8.3%
  • 12.37%
  • 1.15%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 13.63
  • 9.46
  • 8.89

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 15.26
  • 7.14
  • 6.34

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 20.32
  • 8.75
  • 15.07

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 26.58
  • 24.15
  • 25.87

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 7.28
  • 4.91
  • 4.97

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 18.09
  • 15.63
  • 16.07

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 22
Jun 21
Var%
Mar 22
Mar 21
Var%
Dec 21
Dec 20
Var%
Sep 21
Sep 20
Var%
Net Sales
950.93
747.99
27.13%
870.29
756.84
14.99%
837.91
748.74
11.91%
884.80
715.91
23.59%
Expenses
729.17
527.78
38.16%
663.60
497.43
33.41%
598.33
507.06
18.00%
621.98
441.66
40.83%
EBITDA
221.76
220.21
0.70%
206.69
259.41
-20.32%
239.58
241.68
-0.87%
262.82
274.25
-4.17%
EBIDTM
23.32%
29.44%
23.75%
34.28%
28.59%
32.28%
29.70%
38.31%
Other Income
32.76
32.63
0.40%
29.48
2.53
1,065.22%
24.03
5.48
338.50%
29.54
4.85
509.07%
Interest
0.88
1.51
-41.72%
7.34
2.56
186.72%
0.95
2.55
-62.75%
0.40
1.53
-73.86%
Depreciation
31.78
30.88
2.91%
31.16
30.60
1.83%
31.72
29.14
8.85%
31.54
28.33
11.33%
PBT
221.86
220.45
0.64%
197.67
228.78
-13.60%
230.94
215.47
7.18%
260.42
249.24
4.49%
Tax
47.24
46.70
1.16%
46.46
69.52
-33.17%
39.16
38.84
0.82%
64.48
79.02
-18.40%
PAT
174.62
173.75
0.50%
151.21
159.26
-5.05%
191.78
176.63
8.58%
195.94
170.22
15.11%
PATM
18.36%
23.23%
17.37%
21.04%
22.89%
23.59%
22.15%
23.78%
EPS
13.58
13.32
1.95%
11.74
12.21
-3.85%
14.70
13.54
8.57%
15.02
12.94
16.07%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Net Sales
3,543.93
3,340.99
2,889.69
2,587.87
2,055.37
2,125.76
1,983.26
1,733.98
1,473.56
1,208.34
930.84
Net Sales Growth
19.35%
15.62%
11.66%
25.91%
-3.31%
7.19%
14.38%
17.67%
21.95%
29.81%
 
Cost Of Goods Sold
941.03
677.73
514.99
537.75
295.72
317.35
322.58
317.33
290.33
283.98
250.11
Gross Profit
2,602.90
2,663.26
2,374.70
2,050.12
1,759.65
1,808.41
1,660.68
1,416.65
1,183.23
924.36
680.73
GP Margin
73.45%
79.71%
82.18%
79.22%
85.61%
85.07%
83.73%
81.70%
80.30%
76.50%
73.13%
Total Expenditure
2,613.08
2,411.70
1,891.13
1,904.55
1,488.94
1,467.37
1,296.38
1,146.92
968.33
839.59
706.35
Power & Fuel Cost
-
54.38
43.70
38.88
32.65
27.42
18.70
15.49
12.91
11.20
10.25
% Of Sales
-
1.63%
1.51%
1.50%
1.59%
1.29%
0.94%
0.89%
0.88%
0.93%
1.10%
Employee Cost
-
645.78
548.25
485.59
430.71
376.47
295.42
256.64
200.58
156.97
123.18
% Of Sales
-
19.33%
18.97%
18.76%
20.96%
17.71%
14.90%
14.80%
13.61%
12.99%
13.23%
Manufacturing Exp.
-
275.42
226.20
204.81
174.78
215.80
192.70
174.40
130.81
96.29
81.76
% Of Sales
-
8.24%
7.83%
7.91%
8.50%
10.15%
9.72%
10.06%
8.88%
7.97%
8.78%
General & Admin Exp.
-
221.86
131.64
159.49
149.90
131.92
92.02
66.24
50.99
47.40
37.02
% Of Sales
-
6.64%
4.56%
6.16%
7.29%
6.21%
4.64%
3.82%
3.46%
3.92%
3.98%
Selling & Distn. Exp.
-
479.26
374.73
413.70
320.99
306.30
270.92
245.92
233.96
201.57
169.99
% Of Sales
-
14.34%
12.97%
15.99%
15.62%
14.41%
13.66%
14.18%
15.88%
16.68%
18.26%
Miscellaneous Exp.
-
57.27
51.62
64.33
84.19
92.11
104.04
70.90
48.75
42.18
169.99
% Of Sales
-
1.71%
1.79%
2.49%
4.10%
4.33%
5.25%
4.09%
3.31%
3.49%
3.66%
EBITDA
930.85
929.29
998.56
683.32
566.43
658.39
686.88
587.06
505.23
368.75
224.49
EBITDA Margin
26.27%
27.81%
34.56%
26.40%
27.56%
30.97%
34.63%
33.86%
34.29%
30.52%
24.12%
Other Income
115.81
115.68
25.98
92.19
21.08
24.16
23.86
21.15
16.80
13.71
5.60
Interest
9.57
10.20
8.27
11.91
1.16
0.41
1.36
4.89
5.92
8.73
19.13
Depreciation
126.20
125.29
116.09
95.71
72.08
59.59
61.21
44.43
51.64
43.88
34.17
PBT
910.89
909.48
900.18
667.89
514.27
622.55
648.17
558.89
464.47
329.85
176.79
Tax
197.34
196.80
246.31
196.27
127.30
153.91
141.34
143.28
146.15
95.97
64.68
Tax Rate
21.66%
21.64%
27.36%
29.56%
24.75%
24.72%
21.81%
25.64%
32.05%
29.10%
36.59%
PAT
713.55
712.68
653.87
467.70
386.97
468.64
506.83
415.61
309.86
233.88
112.11
PAT before Minority Interest
713.55
712.68
653.87
467.70
386.97
468.64
506.83
415.61
309.86
233.88
112.11
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
20.13%
21.33%
22.63%
18.07%
18.83%
22.05%
25.56%
23.97%
21.03%
19.36%
12.04%
PAT Growth
4.96%
8.99%
39.81%
20.86%
-17.43%
-7.54%
21.95%
34.13%
32.49%
108.62%
 
EPS
55.70
55.63
51.04
36.51
30.21
36.58
39.57
32.44
24.19
18.26
8.75

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Shareholder's Funds
3,264.34
2,995.63
2,598.87
2,245.21
2,041.37
1,567.69
1,190.86
841.09
593.31
393.43
Share Capital
17.17
17.39
17.54
17.54
17.69
17.69
17.69
17.68
17.67
11.80
Total Reserves
3,246.87
2,977.70
2,580.86
2,226.57
2,022.05
1,550.00
1,173.17
822.98
575.06
381.13
Non-Current Liabilities
278.64
274.55
227.61
162.23
38.56
8.90
28.63
55.67
80.62
102.46
Secured Loans
1.64
1.60
0.74
0.66
1.01
1.04
5.79
23.31
41.53
57.57
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
9.08
9.94
10.77
15.76
Long Term Provisions
209.66
208.12
155.01
134.15
13.16
4.88
2.59
4.76
2.83
2.98
Current Liabilities
837.73
838.82
745.53
498.35
346.05
246.66
259.89
249.59
275.42
222.34
Trade Payables
327.17
373.86
362.34
225.18
249.63
178.18
145.57
109.06
124.54
131.71
Other Current Liabilities
301.47
214.14
180.12
111.45
63.95
46.33
56.72
58.33
47.63
19.45
Short Term Borrowings
0.00
0.00
42.85
33.34
0.00
0.00
46.25
17.90
60.55
51.26
Short Term Provisions
209.09
250.82
160.22
128.38
32.47
22.15
11.35
64.30
42.70
19.92
Total Liabilities
4,380.71
4,109.00
3,572.01
2,905.79
2,425.98
1,823.25
1,479.38
1,146.35
949.35
718.23
Net Block
1,511.99
1,541.11
1,472.14
1,168.35
1,052.66
589.17
450.74
288.09
279.39
272.56
Gross Block
2,217.79
2,140.80
1,976.15
1,578.96
1,417.23
894.94
715.73
549.85
492.00
438.49
Accumulated Depreciation
705.80
599.69
504.01
410.61
364.57
305.77
264.99
261.76
212.61
165.93
Non Current Assets
1,925.91
1,891.22
1,790.94
1,605.27
1,202.36
972.65
716.11
512.94
429.30
349.21
Capital Work in Progress
152.86
108.19
131.86
261.61
61.33
254.22
198.91
170.20
93.55
12.49
Non Current Investment
25.10
0.00
12.28
22.87
7.58
0.00
0.00
40.04
8.46
8.46
Long Term Loans & Adv.
229.26
230.74
164.20
148.36
76.79
41.88
21.29
9.34
39.15
48.61
Other Non Current Assets
6.70
11.18
10.46
4.08
4.00
2.34
4.28
5.27
8.75
7.09
Current Assets
2,454.80
2,217.78
1,781.07
1,300.52
1,223.62
850.60
763.27
633.41
520.05
369.02
Current Investments
121.86
175.67
67.14
64.74
182.38
181.56
76.78
19.46
55.00
0.00
Inventories
791.07
766.47
495.68
435.71
350.63
211.02
204.58
159.03
155.40
147.60
Sundry Debtors
1,019.81
738.43
775.30
459.48
459.79
323.15
372.35
258.76
202.22
150.47
Cash & Bank
211.79
209.61
205.25
100.51
93.09
69.95
43.37
136.76
60.39
46.23
Other Current Assets
310.27
104.15
69.02
96.63
137.73
64.92
66.19
59.40
47.04
24.72
Short Term Loans & Adv.
231.54
223.45
168.68
143.45
23.11
56.29
59.39
47.43
43.66
20.72
Net Current Assets
1,617.07
1,378.96
1,035.54
802.17
877.57
603.94
503.38
383.82
244.63
146.68
Total Assets
4,380.71
4,109.00
3,572.01
2,905.79
2,425.98
1,823.25
1,479.38
1,146.35
949.35
718.23

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Cash From Operating Activity
562.04
576.31
456.77
374.51
281.12
609.29
326.14
279.42
212.42
234.27
PBT
909.48
900.18
663.97
514.27
622.56
648.17
558.90
456.01
329.85
163.51
Adjustment
92.08
115.27
70.79
61.93
52.48
86.33
53.07
51.21
50.82
65.28
Changes in Working Capital
-200.39
-208.75
-123.16
-83.46
-254.32
25.88
-124.34
-81.69
-74.52
38.60
Cash after chg. in Working capital
801.17
806.70
611.60
492.74
420.72
760.38
487.63
425.53
306.15
267.39
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-239.13
-230.39
-154.83
-118.23
-139.60
-151.09
-161.49
-146.11
-93.73
-33.12
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-74.10
-282.38
-224.40
-222.78
-256.11
-383.12
-209.07
-158.36
-187.80
-103.70
Net Fixed Assets
-121.31
-137.02
-255.91
-361.08
-327.21
-235.38
-197.00
-138.00
-120.60
-68.66
Net Investments
-7.97
-71.11
7.11
107.76
-1.82
-104.79
-17.41
2.22
-59.98
-1.81
Others
55.18
-74.25
24.40
30.54
72.92
-42.95
5.34
-22.58
-7.22
-33.23
Cash from Financing Activity
-460.04
-318.29
-128.63
-147.46
-0.20
-201.77
-117.32
-105.19
-20.13
-104.49
Net Cash Inflow / Outflow
27.90
-24.36
103.74
4.27
24.81
24.40
-0.25
15.87
4.49
26.08
Opening Cash & Equivalents
177.51
202.35
95.16
90.64
65.83
41.42
41.67
38.62
34.13
8.05
Closing Cash & Equivalent
205.41
177.99
198.90
94.91
90.64
65.82
41.42
54.49
38.62
34.13

Financial Ratios

Consolidated /

Standalone
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Book Value (Rs.)
254.80
230.83
297.80
257.19
231.78
178.14
135.31
95.57
67.42
44.73
ROA
16.79%
17.03%
14.44%
14.52%
22.06%
30.69%
31.66%
29.57%
28.05%
16.40%
ROE
22.77%
23.38%
19.32%
18.07%
25.98%
36.75%
40.92%
43.24%
47.47%
32.46%
ROCE
29.37%
32.20%
27.44%
23.84%
34.49%
45.74%
51.61%
56.43%
54.53%
38.62%
Fixed Asset Turnover
1.56
1.43
1.46
1.37
1.84
2.49
2.76
2.85
2.61
2.29
Receivable days
94.50
93.66
87.08
81.62
67.06
63.41
65.84
56.64
52.93
56.78
Inventory Days
83.71
78.09
65.68
69.82
48.10
37.89
37.93
38.64
45.48
61.44
Payable days
188.77
260.89
59.55
63.24
57.26
50.30
41.91
46.38
59.31
61.76
Cash Conversion Cycle
-10.56
-89.14
93.21
88.21
57.90
51.01
61.86
48.91
39.10
56.46
Total Debt/Equity
0.00
0.00
0.02
0.02
0.00
0.00
0.07
0.09
0.22
0.32
Interest Cover
90.16
109.85
56.75
444.34
1519.41
477.60
115.29
78.03
38.78
10.24

News Update:


  • Ajanta Pharma gets 2 procedural observation from USFDA for Dahej unit
    12th Sep 2022, 12:28 PM

    USFDA has conducted inspection at Dahej unit from September 05, 2022 to September 09, 2022

    Read More
  • Ajanta Pharma - Quarterly Results
    28th Jul 2022, 16:07 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.